NDC 62332-199-10 - Asenapine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62332-199
- Requested NDC
- 62332-199-10
- Package NDCs from labels
- 62332-199-10, 62332-199-60, 62332-199-31
- Manufacturer
- Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited
- Effective date
- 2025-02-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Asenapine - Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 2025-02-25 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62332-199-10 | Asenapine | 10 in 1 BLISTER PACK | TABLET | 10 | 16 | |
| 62332-199-31 | Asenapine | 100 in 1 CARTON | TABLET | 100 | 16 | |
| 62332-199-31 | Asenapine | 10 in 1 BLISTER PACK | TABLET | 10 | 16 | |
| 62332-199-60 | Asenapine | 60 in 1 CARTON | TABLET | 60 | 16 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62332-199-10 | EA - Each | 62332-199 | e443fb7e-707e-4b23-9277-7d974e66ea33 | 1 | 2022-03-09 |
| 62332-199-31 | EA - Each | 62332-199 | 5a33e162-4428-4cf7-acd9-c676943686f5 | 1 | 2021-01-08 |
| 62332-199-60 | EA - Each | 62332-199 | a9410d63-5754-4755-b80d-8f8860705b38 | 1 | 2021-01-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| ASENAPINE | ASENAPINE | Sigmapharm Laboratories, LLC | 3512687b-d1c7-45c4-8822-3a2ad53575a5 | 2025-11-25 | Boxed warning, Warnings, Adverse reactions | 859981 859975 JKZ19V908O |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| Asenapine | ASENAPINE | Alembic Pharmaceuticals Inc. | 16e1cc9f-7699-49ea-b179-acb65e162304 | 2025-02-25 | Boxed warning, Warnings, Adverse reactions | ANDA206098 62332-544-60 62332-199-60 62332-544-10 62332-198-31 62332-198-60 62332-199-31 62332-199-10 62332-198-10 62332-544-31 62332-198 62332-199 62332-544 62332019910 859981 1606337 859975 d54a0a82-b197-46eb-9c1d-4e77960d6f60 16e1cc9f-7699-49ea-b179-acb65e162304 JKZ19V908O |
| SAPHRIS | ASENAPINE MALEATE | Allergan, Inc. | 5429f134-839f-4ffc-9944-55f51238def8 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | 859981 1606337 859975 |
| SECUADO | ASENAPINE | Noven Therapeutics, LLC | 685eaf44-5944-4f38-afba-0a4fc0b3462b | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | JKZ19V908O |
| Multi-Phenolic | MANNOSE, 5-HYDROXYTRYPTOPHAN, ACETALDEHYDE, ACETYLCHOLINE CHLORIDE, ASCORBICUM ACIDUM, ASPARTAME, BUTYLATED HYDROXYTOLUENE, CAFFEIC ACID, CANDIDA ALBICANS, CINNAMIC ACID, CONIFERYL ALCOHOL, COUMARINUM, DOPAMINE HYDROCHLORIDE, ESTRADIOL, GABA (GAMMA-AMINOBUTYRIC ACID), GALLICUM ACIDUM, HISTAMINUM HYDROCHLORICUM, HYDROCORTISONE, INDOLUM, L-DOPA, L-PHENYLALANINE, MELATONIN, MENADIONE, NOREPINEPHRINE (BITARTRATE), PETROSELINUM CRISPUM, PHENYL ISOTHIOCYANATE, PIPERINE, PROGESTERONE, PYRROLE, QUERCETIN, | Energique, Inc. | 492b412a-01cc-48f2-bcdc-6fffcc651963 | 2024-08-23 | Warnings | 1P9D0Z171K |
| Asenapine | ASENAPINE MALEATE | Breckenridge Pharmaceutical, Inc. | f5cd9abb-40e3-4cb5-a1b2-40cdba8a1c7e | 2024-02-13 | Boxed warning, Warnings, Adverse reactions | 859981 1606337 859975 |
| MANNITOL | MANNITOL | HF Acquisition Co LLC, DBA HealthFirst | 999ce711-2d5b-0d7d-e053-2995a90a2689 | 2024-01-27 | Warnings, Adverse reactions | 3OWL53L36A |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 1P9D0Z171K |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 1P9D0Z171K |
| Anubis Barcelona Vital Line | HYDROLYZED ELASTIN, HYDROLYSED COLLAGEN, COCOGLYCERIDES | ANUBIS COSMETICS SL | ebe024f7-7c45-ad60-e053-2995a90a45d6 | 2023-09-01 | Warnings | 1P9D0Z171K |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 1P9D0Z171K |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | 1P9D0Z171K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.